These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3899444)

  • 1. The fibrinolytic system of the vascular wall.
    Erickson LA; Schleef RR; Ny T; Loskutoff DJ
    Clin Haematol; 1985 Jun; 14(2):513-30. PubMed ID: 3899444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The vascular wall and fibrinolysis--physiologic aspects].
    Binder BR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):151-63. PubMed ID: 2427396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The vascular wall and fibrinolysis--pharmacologic aspects].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):164-75. PubMed ID: 2427397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
    Hayashi T
    Rinsho Byori; 1994 Apr; 42(4):346-51. PubMed ID: 8176842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolysis modulators].
    Machovich R
    Orv Hetil; 2002 Mar; 143(11):541-5. PubMed ID: 12583322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors.
    Schleef RR; Loskutoff DJ
    Haemostasis; 1988; 18(4-6):328-41. PubMed ID: 3148526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
    Shen GX
    Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in knowledge about fibrinolysis regulation].
    Cierniewski CS
    Acta Haematol Pol; 1994; 25(2 Suppl 2):15-26. PubMed ID: 7998470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.